Medical device and healthcare consumer products for wound care and chronic disease management
URGO Group is a 1,000–5,000-person pharmaceutical and medical device manufacturer headquartered in Paris, operating across advanced wound care, self-care products, and connected health. The company runs a SAP-centric ERP stack (S/4HANA, ECC, SD) paired with DocuSign for contracting—typical of a regulated, multi-subsidiary operation. Active hiring spans finance, engineering, research, and legal across France, Italy, and Belgium, with a notable shift toward O2C functional leadership and treasury optimization, suggesting post-acquisition consolidation and cash-management standardization across subsidiaries.
Notable leadership hires: Functional O2C Lead
URGO Group manufactures and distributes medical devices and consumer healthcare products focused on wound management, self-care, and preventive health. The group operates three core business units: URGO Medical (advanced wound care and diabetic care solutions backed by clinical evidence), URGO Healthcare (over-the-counter wellness brands), and partner brands including Juva Santé and Super Diet. The company serves healthcare professionals and direct consumers across Europe, with particular strength in France and expanding operations in Italy and Belgium. Current initiatives include e-commerce deployment, subsidiary restructuring, and market expansion in compression therapy and artificial skin technologies.
URGO operates SAP as its core platform, including S/4HANA, ECC, and SD (Sales & Distribution) modules. The company is actively managing a transition to S/4HANA while maintaining EDI connectivity for supply chain integration.
URGO manufactures advanced wound-care devices (targeting diabetic and chronic wounds), over-the-counter self-care and prevention products under the URGO Healthcare, Juva Santé, and Super Diet brands, and is developing artificial skin technologies and compression therapy solutions.
Other companies in the same industry, closest in size